Treatment Individualization in Colorectal Cancer

Colorectal cancer has been characterized as a genetically heterogeneous disease, with a large diversity in molecular pathogenesis resulting in differential responses to therapy. However, the currently available validated biomarkers KRAS, BRAF, and microsatellite instability do not sufficiently cover...

Descripción completa

Detalles Bibliográficos
Autores principales: van Geel, Robin M. J. M., Beijnen, Jos H., Bernards, René, Schellens, Jan H.M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2015
Materias:
Therapeutic Approaches to Metastatic Colorectal Cancers (L Vecchione, Section Editor)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4653238/
https://www.ncbi.nlm.nih.gov/pubmed/26617477
http://dx.doi.org/10.1007/s11888-015-0288-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4653238/
https://www.ncbi.nlm.nih.gov/pubmed/26617477
http://dx.doi.org/10.1007/s11888-015-0288-z

Ejemplares similares